Molecular mechanisms of hepatocellular carcinoma
Top Cited Papers
- 14 August 2008
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 48 (6), 2047-2063
- https://doi.org/10.1002/hep.22580
Abstract
Hepatocellular carcinoma (HCC) typically has poor prognosis, because it is often diagnosed at an advanced stage. Heterogeneous phenotypic and genetic traits of affected individuals and a wide range of risk factors have classified it a complex disease. HCC is not amenable to standard chemotherapy and is resistant to radiotherapy. In most cases, surgical resection and liver transplantation remain the only curative treatment options. Therefore, development of novel, effective therapies is of prime importance. Extensive research over the past decade has identified a number of molecular biomarkers as well as cellular networks and signaling pathways affected in liver cancer. Recent studies using a combination of “omics” technologies, microRNA studies, combinatorial chemistry, and bioinformatics are providing new insights into the gene expression and protein profiles during various stages of the disease. In this review, we discuss the contribution of these newer approaches toward an understanding of molecular mechanisms of HCC and for the development of novel cancer therapeutics. (HEPATOLOGY 2008;48:2047‐2063.)Keywords
This publication has 176 references indexed in Scilit:
- Identification of metastasis-related microRNAs in hepatocellular carcinomaHepatology, 2008
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomasHepatology, 2006
- The retinoblastoma tumor-suppressor gene, the exception that proves the ruleOncogene, 2006
- Downregulation of miR‐122 in the rodent and human hepatocellular carcinomasJournal of Cellular Biochemistry, 2006
- Proteomic analysis of hepatitis B virus‐associated hepatocellular carcinoma: Identification of potential tumor markersProteomics, 2005
- Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosisHepatology, 2005
- Current two‐dimensional electrophoresis technology for proteomicsProteomics, 2004
- Protein analysis on a proteomic scaleNature, 2003
- Apoptosis of human BEL-7402 hepatocellular carcinoma cells released by antisense H-ras DNA-in vitro and in vivo studiesZeitschrift für Krebsforschung und Klinische Onkologie, 1997